Results 201 to 210 of about 14,063,189 (364)

Integrative analysis of circulating tumor cells (CTCs) and exosomes from small‐cell lung cancer (SCLC) patients: a comprehensive approach

Molecular Oncology, EarlyView.
This study simultaneously investigated circulating tumor cells (CTCs) and exosomes from small‐cell lung cancer (SCLC) patients. The elevated expression of JUNB and CXCR4 in CTCs was a poor prognostic factor for SCLC patients, whereas exosomal overexpression of these biomarkers revealed a high discrimination ability of patients from healthy individuals,
Dimitrios Papakonstantinou, Argyro Roumeliotou, Evangelia Pantazaka, Athanasios‐Nasir Shaukat, Athina Christopoulou, Angelos Koutras, Foteinos‐Ioannis Dimitrakopoulos, Vassilis Georgoulias, Anastasia Xagara, Evangelia Chantzara, Fillipos Koinis, Athanasios Kotsakis, Constantinos Stathopoulos, Galatea Kallergi   +13 more
wiley   +1 more source

In the Race to Help with Covid-19, Time Is Precious: Editorial Guidelines for Coronavirus Papers

iScience, 2020
Simona Fiorani, Stefano Tonzani
doaj  

Elevated Blood Lead Levels in a Pregnant Woman and her Family from Traditional Kansa (Bronze) and Pital (Brass) Metalware - New York City, 2024. [PDF]

MMWR Morb Mortal Wkly Rep
Hore P, Alex-Oni K, Sedlar S, Bardhi N, Ehrlich J.   +4 more
europepmc   +1 more source

On a Remarkable Effect upon the Human Gums Produced by the Absorption of Lead [PDF]

Henry Burton
openalex   +1 more source

The lattice spacings of lead-rich substitutional solid solutions [PDF]

, 1954
C. Tyzack, G. V. Raynor
openalex   +1 more source

Detection rate for ESR1 mutations is higher in circulating‐tumor‐cell‐derived genomic DNA than in paired plasma cell‐free DNA samples as revealed by ddPCR

Molecular Oncology, EarlyView.
Analysis of ESR1 mutations in plasma cell‐free DNA (cfDNA) is highly important for the selection of treatment in patients with breast cancer. Using multiplex‐ddPCR and identical blood draws, we investigated whether circulating tumor cells (CTCs) and cfDNA provide similar or complementary information for ESR1 mutations.
Stavroula Smilkou, Aliki Ntzifa, Victoria Tserpeli, Ioanna Balgkouranidou, Alkistis Papatheodoridi, Evangelia Razis, Helena Linardou, Christos Papadimitriou, Amanda Psyrri, Flora Zagouri, Stylianos Kakolyris, Evi Lianidou   +11 more
wiley   +1 more source

Machine learning and explainable artificial intelligence to predict and interpret lead toxicity in pregnant women and unborn baby. [PDF]

Front Digit Health
Chaurasia P, Yogarajah P, Ali Mahdi A, McClean S, Kaleem Ahmad M, Jafar T, Kumar Singh S.   +6 more
europepmc   +1 more source

Tetra-Ethyl Lead Poisoning [PDF]

, 1946
D. A. K. Cassells, E. C. Dodds
openalex   +1 more source

Cell‐free DNA aneuploidy score as a dynamic early response marker in prostate cancer

Molecular Oncology, EarlyView.
mFast‐SeqS‐based genome‐wide aneuploidy scores are concordant with aneuploidy scores obtained by whole genome sequencing from tumor tissue and can predict response to ARSI treatment at baseline and, at an early time point, to ARSI and taxanes. This assay can be easily performed at low cost and requires little input of cfDNA. Cell‐free circulating tumor
Khrystany T. Isebia, Anouk C. de Jong, Lisanne F. van Dessel, Vanja de Weerd, Corine Beaufort, Jean Helmijr, José Alberto Nakauma‐González, Job van Riet, Paul Hamberg, Daniel Vis, Michiel S. van der Heijden, Nick Beije, Martijn P. Lolkema, Teoman Deger, Saskia M. Wilting, Ronald de Wit, Maurice P. H. M. Jansen, John W. M. Martens   +17 more
wiley   +1 more source

Assessing mercury and lead pollution in the Ankobra estuary due to artisanal mining activities: Implications for water quality and aquatic life. [PDF]

PLoS One
Adebote MO, Aggrey-Fynn J, Mensah PK.
europepmc   +1 more source